CA

Canada

32079 clinical trials

Find Trials

Clinical Trials (32079)

Showing 20 of 32,079 trialsScroll for more
NCT06717347Phase 33 sites

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Recruiting
NCT06453486Phase 22 sites

A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

Recruiting
NCT07152821Phase 317 sites

Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

Recruiting
NCT07285460Phase 31 site

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

Recruiting
NCT07062965Phase 37 sites

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Recruiting
NCT05973110Not Applicable1 site

Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

Recruiting
NCT06331312Phase 31 site

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

Active Not Recruiting
NCT06684847Phase 33 sites

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Active Not Recruiting
NCT06057402Phase 43 sites

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Recruiting
NCT07085767Phase 31 site

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Recruiting
NCT06641466Phase 37 sites

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Recruiting

Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Recruiting
NCT04421963Phase 311 sites

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Active Not Recruiting
NCT06830798Phase 35 sites

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Recruiting
NCT06291376Phase 34 sites

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
NCT05442567Phase 33 sites

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Recruiting
NCT05156398Phase 31 site

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Recruiting
NCT05166889Phase 314 sites

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Completed
NCT03114319Phase 11 site

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Terminated
NCT04856059Not Applicable1 site

Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

Recruiting